Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Butamben is a local anesthetic of the ester type used primarily for topical anesthesia of mucous membranes (excluding the eyes). It is chemically known as n-butyl-p-aminobenzoate and acts by inhibiting voltage-gated calcium channels (including T-type and N-type) and sodium channels in dorsal root ganglion neurons. This results in reduced electrical excitability and selective inhibition of pain signal transmission through C fibers without significant loss of motor function. Due to its low water solubility, it is suitable only for topical use. It is commonly found as a component in multi-agent topical anesthetics such as Cetacaine. The FDA has removed parenteral forms from the market due to poor solubility[1][2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on butamben.